Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Staessen

Showing results (11-20 of 172) with videos related to

Pageof 18
Sort By:
Lancet (London, England)|May 20, 1999
What is "hypertension"?E O'Brien, J A Staessen
Lancet (London, England)|October 9, 2001
Blood-pressure lowering for the secondary prevention of strokeJ A Staessen, J Wang
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|September 4, 2009
Genetic variation and environmental factors in biological and arterial ageingT S Nawrot, J A Staessen
Blood Pressure Monitoring|September 22, 1999
Development of diagnostic thresholds for automated measurement of blood pressures in adultsJ A Staessen, E T O'Brien
European Journal of Pharmacology|January 3, 2001
Genetic polymorphisms in the renin-angiotensin system: relevance for susceptibility to cardiovascular diseaseJ G Wang, J A Staessen
The Netherlands Journal of Medicine|June 8, 2001
Benefits of antihypertensive drug treatment in elderly patients with isolated systolic hypertensionJ G Wang, J A Staessen
Drugs & Aging|June 8, 2001
Improved outcomes with antihypertensive medication in the elderly with isolated systolic hypertensionJ G Wang, J A Staessen
Current Hypertension Reports|July 27, 2001
The benefit of treating isolated systolic hypertensionJ G Wang, J A Staessen
Current Opinion in Nephrology and Hypertension|February 27, 2001
Antihypertensive drug therapy in older patientsJ G Wang, J A Staessen
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 28, 1999
Treatment of isolated systolic hypertension in the elderly: the Syst-Eur trial. Systolic Hypertension in Europe (Syst-Eur) Trial InvestigatorsR H Fagard, J A Staessen
Pageof 18

Showing results (11-20 of 172) with videos related to

Sort By:
Pageof 18
Lancet (London, England)|May 20, 1999
What is "hypertension"?E O'Brien, J A Staessen
Lancet (London, England)|October 9, 2001
Blood-pressure lowering for the secondary prevention of strokeJ A Staessen, J Wang
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|September 4, 2009
Genetic variation and environmental factors in biological and arterial ageingT S Nawrot, J A Staessen
Blood Pressure Monitoring|September 22, 1999
Development of diagnostic thresholds for automated measurement of blood pressures in adultsJ A Staessen, E T O'Brien
European Journal of Pharmacology|January 3, 2001
Genetic polymorphisms in the renin-angiotensin system: relevance for susceptibility to cardiovascular diseaseJ G Wang, J A Staessen
The Netherlands Journal of Medicine|June 8, 2001
Benefits of antihypertensive drug treatment in elderly patients with isolated systolic hypertensionJ G Wang, J A Staessen
Drugs & Aging|June 8, 2001
Improved outcomes with antihypertensive medication in the elderly with isolated systolic hypertensionJ G Wang, J A Staessen
Current Hypertension Reports|July 27, 2001
The benefit of treating isolated systolic hypertensionJ G Wang, J A Staessen
Current Opinion in Nephrology and Hypertension|February 27, 2001
Antihypertensive drug therapy in older patientsJ G Wang, J A Staessen
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 28, 1999
Treatment of isolated systolic hypertension in the elderly: the Syst-Eur trial. Systolic Hypertension in Europe (Syst-Eur) Trial InvestigatorsR H Fagard, J A Staessen
Pageof 18